ReviewJournal of clinical medicine2022

Randomized Controlled Trials on Renin Angiotensin Aldosterone System Inhibitors in Chronic Kidney Disease Stages 3-5: Are They Robust? A Fragility Index Analysis.

Ivana Capuano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.